Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

None (NSTG)

  • Event
  • Oct. 20, 2025, 19:11 UTC
  • 9
  • 1 comments

(NSTG) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Guardant Health Inc (GH)

  • Event
  • Oct. 20, 2025, 19:08 UTC
  • 8
  • 1 comments

Guardant Health Inc (GH) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Sangamo Therapeutics Inc (SGMO)

  • Event
  • Oct. 20, 2025, 19:06 UTC
  • 9
  • 1 comments

Sangamo Therapeutics Inc (SGMO) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Sana Biotechnology Inc (SANA)

  • Event
  • Oct. 20, 2025, 19:06 UTC
  • 7
  • 1 comments

Sana Biotechnology Inc (SANA) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • Event
  • Oct. 20, 2025, 19:04 UTC
  • 8
  • 1 comments

Protagonist Therapeutics Inc (PTGX) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Allakos Inc (ALLK)

  • Event
  • Oct. 20, 2025, 18:55 UTC
  • 5
  • 1 comments

Allakos Inc. (ALLK) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Gritstone Oncology Inc (GRTS)

  • Event
  • Oct. 20, 2025, 18:53 UTC
  • 5
  • 1 comments

Gritstone bio, Inc. (GRTS) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Iovance Biotherapeutics Inc (IOVA)

  • Event
  • Oct. 20, 2025, 18:53 UTC
  • 0
  • 1 comments

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Repare Therapeutics Inc (RPTX)

  • Event
  • Oct. 20, 2025, 18:47 UTC
  • 0
  • 1 comments

Repare Therapeutics Inc. (RPTX) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text

Lyell Immunopharma (LYEL)

  • Event
  • Oct. 20, 2025, 18:44 UTC
  • 0
  • 1 comments

Lyell Immunopharma, Inc. (LYEL) Files Form 10-Q for Period Ending 2022-08-04

Comment Full text
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next

Search

News categories

  • Technical Exchange News(10264)
  • Event(1436)
  • SEC News(174032)
  • FDA Approval(9600)
  • Company Report(721)
  • Business News(116849)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin